IRIS
PENNISI, MARIA STELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.051
EU - Europa 535
AS - Asia 450
SA - Sud America 170
AF - Africa 121
OC - Oceania 1
Totale 2.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.036
IT - Italia 252
SG - Singapore 213
BR - Brasile 157
CN - Cina 119
IE - Irlanda 95
CI - Costa d'Avorio 74
DE - Germania 52
IN - India 42
SN - Senegal 35
VN - Vietnam 30
RU - Federazione Russa 26
FI - Finlandia 21
GB - Regno Unito 19
BE - Belgio 12
CA - Canada 11
CZ - Repubblica Ceca 8
SE - Svezia 8
PL - Polonia 7
TR - Turchia 7
UZ - Uzbekistan 7
JP - Giappone 6
UA - Ucraina 6
AR - Argentina 5
IQ - Iraq 5
KR - Corea 5
CH - Svizzera 4
ES - Italia 4
FR - Francia 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
IL - Israele 3
MA - Marocco 3
MX - Messico 3
ZA - Sudafrica 3
BD - Bangladesh 2
CO - Colombia 2
GR - Grecia 2
HK - Hong Kong 2
HU - Ungheria 2
KE - Kenya 2
NG - Nigeria 2
NL - Olanda 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 2.328
Salva come PNG Salva come JPEG
Città #
Santa Clara 209
Chandler 194
Singapore 145
Chicago 101
Dublin 95
Abidjan 74
Dallas 65
Catania 61
Ashburn 39
Civitanova Marche 34
Dakar 34
Beijing 33
Kochi 32
Boardman 31
Cambridge 27
Lawrence 25
Los Angeles 25
Andover 24
Grafing 23
Dong Ket 22
Wilmington 17
Munich 16
The Dalles 15
Des Moines 14
Columbus 13
Brussels 12
Council Bluffs 12
Turku 12
New York 11
Palermo 11
São Paulo 11
Hefei 10
Nanjing 10
Santa Venerina 9
Belo Horizonte 8
Brno 8
Hanoi 8
Helsinki 8
Bari 7
Milan 6
Pune 6
Tokyo 6
Aci Catena 5
Seattle 5
Seoul 5
Toronto 5
Bremen 4
Edinburgh 4
Falls Church 4
Frankfurt am Main 4
Giardini-Naxos 4
Houston 4
Jiaxing 4
Saint Petersburg 4
Tremestieri Etneo 4
Catanzaro 3
Fantina 3
Guarulhos 3
Hanover 3
Jinan 3
Johannesburg 3
London 3
Manaus 3
Manchester 3
Messina 3
Montreal 3
Oslo 3
Rio de Janeiro 3
San Giovanni la Punta 3
Tashkent 3
Volta Redonda 3
Warsaw 3
Woodbridge 3
Abuja 2
Baghdad 2
Belém 2
Blumenau 2
Boston 2
Cabo Frio 2
Campo Grande 2
Casablanca 2
Chennai 2
Comiso 2
Cáceres 2
Dubai 2
Fairfield 2
Istanbul 2
Jacksonville 2
Joinville 2
Madrid 2
Marília 2
Mascali 2
Mexico City 2
Moscow 2
Nairobi 2
Nanchang 2
Newham 2
Ottawa 2
Quito 2
San Francisco 2
Totale 1.687
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 162
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 119
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 112
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 102
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 96
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 95
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 93
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 93
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 93
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 92
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 89
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 89
New insights in thyroid cancer and p53 family proteins 88
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 85
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 83
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 80
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 78
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 77
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 77
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 74
Opportunities and challenges of liquid biopsy in thyroid cancer 73
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 71
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 67
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 66
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 65
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 63
The Role of New Technologies in Myeloproliferative Neoplasms 59
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 58
Totale 2.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.881
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021103 0 0 3 10 23 5 2 2 26 2 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025959 13 154 38 87 187 132 97 30 31 46 113 31
2025/2026199 97 94 8 0 0 0 0 0 0 0 0 0
Totale 2.399